Generated by Meeveem AI
"A global CRO advancing therapies for small and mid-sized biopharma through clinical development."
Allucent delivers full-service clinical research solutions for small and mid-sized biopharma companies navigating drug development from early stage through post-approval. Combining deep therapeutic expertise in oncology, neuroscience, and infectious diseases with regulatory strategy, clinical operations, biometrics, and pharmacovigilance, Allucent provides nimble support tailored to breakthrough therapies. With over 30 years of experience conducting trials in more than 70 countries, Allucent partners with biotech innovators tackling complex disease states. The company's collaborative approach and global reach help accelerate development timelines and bring innovative treatments to patients worldwide.
850
Team Members
1988
Founded
Contract Research
Sector
Hybrid
Work Environment
A world where innovative therapies from small and mid-sized biotech reach patients faster, transforming outcomes for complex and underserved disease states globally.
Allucent is on a mission to help bring new therapies to light by solving the distinct challenges of small and mid-sized biotech companies.